Generally Recognized as Safe (GRAS) Notices

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form Form FDA 3667 GRAS Notification	Form	Modified	Available
Form Form FDA 3667 Reporting; GRAS Notice under 21 CFR Parts 170 and 570	Form	Modified	Repair queued
0342 GRAS SSA 2025 REV.docx	Supporting Statement A	Uploaded 2025-08-26	Available
0342 GRAS SSA 2025 REV.docx	Supporting Statement A	Uploaded 2025-08-26	Repair queued

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
5950	Reporting; GRAS Notice under 21 CFR Parts 170 and 570	Form	Modified	GRAS Notification
5950	Reporting; GRAS Notice under 21 CFR Parts 170 and 570	Form	Modified
5950	Reporting; GRAS Notice under 21 CFR Parts 170 and 570	Instruction	Modified
273523	Best Practices for Convening a GRAS Panel	Other-Agency Guidance	New

ICR Details

OMB Control No: 0910-0342	ICR Reference No: 202501-0910-001
Status: Active	Previous ICR Reference No: 202204-0910-014
Agency/Subagency: HHS/FDA	Agency Tracking No: HFP
Title: Generally Recognized as Safe (GRAS) Notices
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 09/29/2025
Retrieve Notice of Action (NOA)	Date Received in OIRA: 08/26/2025
Terms of Clearance: Approved with the understanding that FDA will discontinue OMB control number 0910-0911.

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	09/30/2028	36 Months From Approved	09/30/2025
Responses	1,936	0	125
Time Burden (Hours)	31,712	0	21,250
Cost Burden (Dollars)	0	0	0

---

Abstract: This ICR collects information from food manufacturers who wish to obtain a determination from FDA that a food additive is generally recognized as safe (GRAS) and therefore not subject to premarket approval requirements. Respondents submit information as provided in agency regulations regarding GRAS notification, including a description of the substance, intended use, previous communications with the agency, contact information, etc. FDA has developed Form 3667 to facilitate its review of GRAS notices.

---

Authorizing Statute(s): US Code: 21 USC 321 Name of Law: FFDCA
   US Code: 21 USC 348 Name of Law: FFDCA
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 27642	06/27/2025
30-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 41579	08/26/2025
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 2

table that charts list of burden

IC Title	Form No.	Form Name
Best Practices for Convening a GRAS Panel
Reporting; GRAS Notice under 21 CFR Parts 170 and 570	Form FDA 3667	GRAS Notification

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	1,936	125	0	0	1,811	0
Annual Time Burden (Hours)	31,712	21,250	0	0	10,462	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The information collection reflects changes and adjustments. We have consolidated activity attributable to our Best Practices for Convening GRAS Panels guidance while at the same time correcting an inadvertent calculation error in our summary burden table. The result is an increase of 1,811 responses and 10,462 hours, annually. We plan to discontinue OMB control number 0910-0911 upon approval of this request.

---

Annual Cost to Federal Government: $1,561,602

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/26/2025

---